Sanofi Aventis Pakistan Ltd. announced Financial Results for the period ended June 30, 2017.
The company’s Net Sales for the period increased by 16 percent in the outgoing year, whereas the Profit after Taxation for the Period increased by 152 percent.
The board has did not recommend any Cash Dividend, bonus or right shares.
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Six Months Ended
Key Financials
Jan – June, 2017
Jan – Jun, 2016
% Change
Common Size 2017
Amounts in PKR ‘000
Net Sales
6,629,117
5,715,606
15.98%
100%
Cost of SalesGross Profit
4,156,510
3,779,998
9.96%
91%
Gross Profit
2,472,607
1,935,608
27.74%
47%
Dist: & Marketing Expenses
1,122,146
1,165,334
-3.71%
28%
Admin: Expenses
198,623
148,609
33.65%
4%
Other Expenses
210,656
76,393
175.75%
2%
Other income
27,616
17,342
59.24%
0%
Operating Profit
968,798
562,614
72.20%
14%
Finance Costs
27,388
93,583
-70.73%
2%
Profits before Taxation
941,410
469,031
100.71%
11%
Taxation
328,799
226,476
45.18%
5%
Net Profit/(Loss)
612,611
242,555
152.57%
6%
EPS – Basic & Diluted
63.52
25.15
152.56%
0%
Company release on Earnings Report can be accessed here.
